Federal Register / Vol. 86, No. 110 / Thursday, June 10, 2021 / Notices 30983 

import of the Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–12212 Filed 6–9–21; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–845] 

Bulk Manufacturer of Controlled 

Substances Application: Bulk 

Manufacturer of Marihuana: Maridose, 

LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: The Drug Enforcement 

Administration (DEA) is providing 

notice of an application it has received 

from an entity applying to be registered 

to manufacture in bulk basic class(es) of 

controlled substances listed in schedule 

I. DEA intends to evaluate this and other 

pending applications according to its 

regulations governing the program of 

growing marihuana for scientific and 

medical research under DEA 

registration. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefor, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before August 9, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW 8701 

Morrissette Drive, Springfield, Virginia 

22152. To ensure proper handling of 

comments, please reference Docket 

No—DEA–845 in all correspondence, 

including attachments. 

SUPPLEMENTARY INFORMATION: The 

Controlled Substances Act (CSA) 

prohibits the cultivation and 

distribution of marihuana except by 

persons who are registered under the 

CSA to do so for lawful purposes. In 

accordance with the purposes specified 

in 21 CFR 1301.33(a), DEA is providing 

notice that the entity identified below 

has applied for registration as a bulk 

manufacturer of schedule I controlled 

substances. In response, registered bulk 

manufacturers of the affected basic 

class(es), and applicants therefor, may 

file written comments on or objections 

of the requested registration, as 

provided in this notice. This notice does 

not constitute any evaluation or 

determination of the merits of the 

application submitted. 

The applicant plans to manufacture 

bulk active pharmaceutical ingredients 

(APIs) for product development and 

distribution to DEA registered 

researchers. If the application for 

registration is granted, the registrant 

would not be authorized to conduct 

other activity under this registration 

aside from those coincident activities 

specifically authorized by DEA 

regulations. DEA will evaluate the 

application for registration as a bulk 

manufacturer for compliance with all 

applicable laws, treaties, and 

regulations and to ensure adequate 

safeguards against diversion are in 

place. 

As this applicant has applied to 

become registered as a bulk 

manufacturer of marihuana, the 

application will be evaluated under the 

criteria of 21 U.S.C. 823(a). In addition 

to seeking to produce marihuana 

extract, this applicant is separately 

seeking to cultivate marihuana. See 

Notice of Application, Bulk 

Manufacturers of Marihuana, 84 FR 

44920, 44922 (Aug. 27, 2019). DEA thus 

will conduct this evaluation in the 

manner described in the rule published 

at 85 FR 82333 on December 18, 2020, 

and reflected in DEA regulations at 21 

CFR part 1318. 

In accordance with 21 CFR 

1301.33(a), DEA is providing notice that 

on May 6, 2021, Maridose, LLC., 74 

Orion Street, Brunswick, Maine 04011, 

applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substances: 

Controlled substance Drug 

code Schedule 

Marihuana Extract ........ 7350 I 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–12213 Filed 6–9–21; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–843] 

Importer of Controlled Substances 

Application: National Center for 

Natural Products Research 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: National Center for Natural 

Products Research has applied to be 

registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to SUPPLEMENTARY INFORMATION

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before July 12, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

July 12, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for a hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on April 14, 2021, 

National Center for Natural Products 

Research, 806 Hathorn Road, 135 Coy 

Waller Lab, University, Mississippi 

38677–1848, applied to be registered as 

an importer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Marihuana Extract .......... 7350 I 

Marihuana ....................... 7360 I 

Tetrahydrocannabinols ... 7370 I 

The company plans to acquire new 

genetic materials with improved 

Cannabinoids for research and 

manufacturing purposes. No other 

activity for these drug codes is 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of FDA-approved or nonVerDate Sep<11>2014 17:15 Jun 09, 2021 Jkt 253001 PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 E:\FR\FM\10JNN1.SGM 10JNN1

khammond on DSKJM1Z7X2PROD with NOTICES

I I 
30984 Federal Register / Vol. 86, No. 110 / Thursday, June 10, 2021 / Notices 

approved finished dosage forms for 

commercial sale. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–12209 Filed 6–9–21; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Notice of Lodging of Proposed 

Consent Decree Under the Clean Air 

Act 

On June 2, 2021, the Department of 

Justice lodged with the United States 

District Court for the Southern District 

of Indiana a Consent Decree in United 

States and State of Indiana v. Lone Star 

Industries, Inc. Civ. No. 2:21–cv–233– 

JRS–MJD. 

The proposed Consent Decree settles 

claims brought by the United States and 

State of Indiana against Lone Star for 

violations of the Clean Air Act and Title 

13 of the Indiana Code (including 

regulations and permits issued 

thereunder) at the cement 

manufacturing facility it owns and 

operates in Greencastle, Indiana. The 

Consent Decree resolves these claims 

and requires Lone Star to (1) pay a civil 

penalty of $729,000 to be split evenly 

between the state and United States; (2) 

implement specified measures designed 

to prevent the continuation or 

reoccurrence of the violations alleged, 

and (3) complete various mitigation 

projects to offset harm caused by its past 

violations. 

The publication of this notice opens 

a period for public comment on the 

proposed Consent Decree. Comments 

should be addressed to the Assistant 

Attorney General, Environment and 

Natural Resources Division and should 

refer to United States and State of 

Indiana v. Lone Star Industries, Inc. D.J. 

Ref. No. 90–5–2–1–09889/4. All 

comments must be submitted no later 

than thirty (30) days after the 

publication date of this notice. 

Comments may be submitted either by 

email or by mail: 

To submit 

comments: Send them to: 

By email ....... pubcomment-ees.enrd@

usdoj.gov. 

By mail ......... Assistant Attorney General, 

U.S. DOJ—ENRD, P.O. 

Box 7611, Washington, DC 

20044–7611. 

During the public comment period, 

the proposed Consent Decree may be 

examined and downloaded at this 

Justice Department website: https://

www.justice.gov/enrd/consent-decrees. 

We will provide a paper copy of the 

proposed Consent Decree upon written 

request and payment of reproduction 

costs. Please mail your request and 

payment to: Consent Decree Library, 

U.S. DOJ—ENRD, P.O. Box 7611, 

Washington, DC 20044–7611. 

Please enclose a check or money order 

for $12.25 (25 cents per page 

reproduction cost) payable to the United 

States Treasury. 

Patricia A. McKenna, 

Assistant Section Chief, Environmental 

Enforcement Section, Environment and 

Natural Resources Division. 

[FR Doc. 2021–12115 Filed 6–9–21; 8:45 am] 

BILLING CODE 4410–15–P 

DEPARTMENT OF LABOR 

Employment and Training 

Administration 

Notice of a Change in Status of the 

Extended Benefit (EB) Program for 

Colorado 

AGENCY: Employment and Training 

Administration, Labor. 

ACTION: Notice. 

This notice announces a change in 

benefit period eligibility under the EB 

program that has occurred since the 

publication of the last notice regarding 

the State’s EB status: 

• Based on the data released by the 

Bureau of Labor Statistics on May 21, 

2021, the seasonally-adjusted TUR for 

Colorado fell below the 6.5% threshold 

necessary to remain ‘‘on’’ in EB. 

Therefore the payable period in EB for 

Colorado will end on June 12, 2021. 

The trigger notice covering state 

eligibility for the EB program can be 

found at: http://ows.doleta.gov/ 

unemploy/claims_arch.as. 

Information for Claimants 

The duration of benefits payable in 

the EB program, and the terms and 

conditions on which they are payable, 

are governed by the Federal-State 

Extended Unemployment Compensation 

Act of 1970, as amended, and the 

operating instructions issued to the 

states by the U.S. Department of Labor. 

In the case of a state beginning an EB 

period, the State Workforce Agency will 

furnish a written notice of potential 

entitlement to each individual who has 

exhausted all rights to regular benefits 

and is potentially eligible for EB (20 

CFR 615.13(c)(1)). 

Persons who believe they may be 

entitled to EB, or who wish to inquire 

about their rights under the program, 

should contact their State Workforce 

Agency. 

FOR FURTHER INFORMATION CONTACT: U.S. 

Department of Labor, Employment and 

Training Administration, Office of 

Unemployment Insurance Room S– 

4524, Attn: Thomas Stengle, 200 

Constitution Avenue NW, Washington, 

DC 20210, telephone number (202) 693– 

2991 (this is not a toll-free number) or 

by email: Stengle.Thomas@dol.gov. 

Signed in Washington, DC. 

Suzan G. LeVine, 

Principal Deputy Assistant Secretary for 

Employment and Training. 

[FR Doc. 2021–12158 Filed 6–9–21; 8:45 am] 

BILLING CODE 4510–FW–P 

DEPARTMENT OF LABOR 

Mine Safety and Health Administration 

Petitions for Modification of 

Application of Existing Mandatory 

Safety Standards 

AGENCY: Mine Safety and Health 

Administration, Labor. 

ACTION: Notice. 

SUMMARY: This notice includes the 

summaries of three petitions for 

modification submitted to the Mine 

Safety and Health Administration 

(MSHA) by the party listed below. 

DATES: All comments on the petitions 

must be received by MSHA’s Office of 

Standards, Regulations, and Variances 

on or before July 12, 2021. 

ADDRESSES: You may submit your 

comments including the docket number 

of the petition by any of the following 

methods: 

1. Electronic Mail: zzMSHAcomments@dol.gov. Include the docket 

number of the petition in the subject 

line of the message. 

2. Facsimile: 202–693–9441. 

3. Regular Mail or Hand Delivery: 

MSHA, Office of Standards, 

Regulations, and Variances, 201 12th 

Street South, Suite 4E401, Arlington, 

Virginia 22202–5452, Attention: Jessica 

D. Senk, Director, Office of Standards, 

Regulations, and Variances. Persons 

delivering documents are required to 

check in at the receptionist’s desk in 

Suite 4E401. Individuals may inspect 

copies of the petition and comments 

during normal business hours at the 

address listed above. 

MSHA will consider only comments 

postmarked by the U.S. Postal Service or 

proof of delivery from another delivery 

service such as UPS or Federal Express 

on or before the deadline for comments. 

FOR FURTHER INFORMATION CONTACT: 

Jessica Senk, Office of Standards, 


khammond on DSKJM1Z7X2PROD with NOTICES